Avidity Partners Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Avidity Partners Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,105,000	Closed	-$39.8M	–	133
2021 Q2	$39.8M	Buy	4,105,000 +90,000	+2%	+$847K	1.08%	35
2021 Q1	$43.1M	Buy	4,015,000 +829,800	+26%	+$10.3M	1.2%	30
2020 Q4	$46.9M	Buy	3,185,200 +1,439,200	+82%	+$20.8M	1.58%	20
2020 Q3	$24.8M	Buy	+1,746,000	New	+$17.4M	1.34%	28

Other funds holding TRIL

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Omni Partners US Irvine, California $1.95B AUM

UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return